LESLIE GUTIERREZ: Open Payments
NPI 1083151476 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,975 in 73 payments from 32 companies in 2025. Trend: 2023 $1,470 · 2024 $1,528 · 2025 $1,975
Food & beverage: $1,875Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $246 |
| ABBVIE INC. | 5 | $222 |
| Merck Sharp & Dohme LLC | 7 | $184 |
| AstraZeneca Pharmaceuticals LP | 6 | $156 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $137 |
| Novartis Pharmaceuticals Corporation | 4 | $112 |
| GlaxoSmithKline, LLC. | 4 | $108 |
| EMD Serono, Inc. | 2 | $69 |
| Tempus AI, Inc | 2 | $52 |
| PFIZER INC. | 3 | $50 |
Products named: KEYTRUDA, Nubeqa, DARZALEX, Enhertu, OJJAARA, XT CDX, Fabhalta, OPDUALAG.
Industry payments across TX — which companies pay providers there.
